Skip to main content

Reversing Atherosclerosis in Multiple Arterial Beds

To provide new hope to patients with peripheral arterial and cardiovascular diseases

Regio Biosciences is committed to the development of novel therapies to reduce plaque burden in the peripheral and coronary arteries and functionally reverse atherosclerosis, providing new hope to patients with cardiovascular disease

Learn More
Medical therapy to directly reduce plaque burden and reverse disease.

Late-stage pipeline to address the major causative factors in peripheral artery disease (PAD) and coronary artery disease (CAD)

Science

Reversing Atherosclerosis in Multiple Arterial Beds

REG-101

Medical therapy to directly reduce plaque burden

Pipeline

Late-stage pipeline to address PAD and CVD